fbpx

Equity Research of
Nordic Growth Companies

Written by 08:00 Analys, Research

MELTRON: Focus set on positive cash flow

After a cash injection of SEK 11.3m from the completed rights issue, Meltron now has its sights set on positive cash flow through sales growth driven by distributors all over northern Europe. While the high potential in Oman, and a potential cooperation with Huawei remains, we’ve revised our sales estimates for 23/24E and 24/25E and now find support for a fair value of SEK 0.22 – 0.27 per share (0.29 – 0.39) in 12-24 months.

Andreas Eriksson | 2022-11-24 08:00 

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and Emergers is not subject to any prohibition on dealing ahead of the dissemination of investment research. This research does not constitute investment advice and is not a solicitation to buy shares. For more information, please refer to disclaimer.  


Cash injection extends runway to positive cash flow
With the aim of raising SEK 16.1m in the recently completed rights issue, which was guaranteed to 64%, subscription rate was somewhat worrying at a mere 22.5% meaning Meltron ended up raising SEK 11.3m while issuing 126 million new shares, diluting non-participating shareholders by 68%. Sales in fiscal year 21/22 amounted to SEK 5m (Jul-Jun), and we estimate that Meltron will need to increase sales to some SEK 40m in order to break even. This means that the company must pick up the pace, if another rights issue is to be avoided. While high-value deals lurk in the distance with global giant Huawei and infrastructure projects in Oman, the short term focus on direct sales and sales through distributors hasn’t yielded much growth so far. Another key focus area for the company has been on lowering costs, which we saw an example of in H1’22 where costs were lowered by 26%. In the upcoming 3–6 months, Meltron will outsource its production which is supposed to lower costs even further, and break even might therefore be reached at lower sales than our estimations.
Looking to capitalize on strong macro trends
With a superior lifespan compared to fluorescent lighting, LED is destined to play a major role in the transition towards a more sustainable society. As a consequense of an EU-decision to ban all lighting containing mercury, more than 17 million lighting fixtures will need to be upgraded in Sweden alone. Meltron has continued down the beaten path and signed a new partnership with a Swedish distributor, as a step on the way to building a vast distribution network across northern Europe to get sales going. Being well-positioned in the premium segment of LED-lights, where entry barriers are a bit higher due to the higher cost, Meltron is set to capitalize on the high gross margins if the company can get sales going.
High potential at high risk
While we continue to see considerable potential for Meltron in Oman, where large amounts are now invested in infrastructure projects, the negotiations seem to have been paused, and Meltron’s focus has instead shifted towards northern Europe. With an estimated pick up in sales to SEK 12m during fiscal year 22/23E, we’ve lowered our estimates for 23/24E and 24/25E to SEK 30m (40m) and SEK 50m (60m) respectively, as a result of the longer lead times in Oman. Based on a combined DCF and target multiple approach we see support of a new fair value of SEK 0.22 – 0.27 per share (0.29-0.39) in 12-24 months, while we continue to see plenty of long term opportunities for high-value deals in Oman and with Huawei.
DISCLAIMER

GENERAL DISCLAIMER AND COPYRIGHT

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers standard fees are SEK 240,000 pa for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.

Copyright: Copyright 2021 Incirrata AB (Emergers)

United Kingdom
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Be first to read new research on growth stocks